Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Harvard Business School
McKesson
Mallinckrodt
Medtronic

Last Updated: November 29, 2022

Bupivacaine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for bupivacaine hydrochloride and what is the scope of patent protection?

Bupivacaine hydrochloride is the generic ingredient in twelve branded drugs marketed by Innocoll Pharms, Civica, Eugia Pharma, Hikma Pharms, Hospira, Steriscience, Intl Medicated, Fresenius Kabi Usa, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, Septodont, and Amphastar Pharms Inc, and is included in forty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Bupivacaine hydrochloride has twenty-six patent family members in fifteen countries.

There are six drug master file entries for bupivacaine hydrochloride. Sixteen suppliers are listed for this compound.

Summary for bupivacaine hydrochloride
International Patents:26
US Patents:1
Tradenames:12
Applicants:13
NDAs:43
Drug Master File Entries: 6
Finished Product Suppliers / Packagers: 16
Raw Ingredient (Bulk) Api Vendors: 106
Clinical Trials: 1,543
Patent Applications: 987
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in bupivacaine hydrochloride?bupivacaine hydrochloride excipients list
DailyMed Link:bupivacaine hydrochloride at DailyMed
Recent Clinical Trials for bupivacaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of SevillePhase 4
Nottingham University Hospitals NHS TrustN/A
Aalborg UniversityN/A

See all bupivacaine hydrochloride clinical trials

US Patents and Regulatory Information for bupivacaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride INJECTABLE;INJECTION 018304-003 Approved Prior to Jan 1, 1982 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 070966-001 Oct 13, 1987 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira MARCAINE HYDROCHLORIDE W/ EPINEPHRINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 016964-008 Approved Prior to Jan 1, 1982 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi Usa SENSORCAINE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 070967-001 Oct 13, 1987 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE bupivacaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 016964-010 Approved Prior to Jan 1, 1982 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 070585-001 Mar 3, 1987 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for bupivacaine hydrochloride

Country Patent Number Title Estimated Expiration
Ireland 20070220 A drug delivery device for providing local analgesia, local anesthesia or nerve blockade See Plans and Pricing
Japan 5372905 See Plans and Pricing
Cyprus 1117814 See Plans and Pricing
Slovenia 3085363 See Plans and Pricing
Slovenia 2139457 See Plans and Pricing
Poland 2139457 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Express Scripts
Colorcon
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.